Best Quantum Stock to Buy on the Dip: D-Wave Quantum (QBTS) or IonQ (IONQ)

IonQ posted 99.99% two-qubit gate fidelity, which the article frames as a competitive edge versus D-Wave's quantum annealing approach. Both stocks remain highly speculative and richly valued, with IonQ at $15.2 billion on $130 million of revenue versus D-Wave at $6.6 billion on $24.6 million of revenue. The piece ultimately favors IonQ as the better dip buy, though it emphasizes long-term volatility and limited near-term commercial visibility.

Analysis

The market is implicitly treating quantum as a one-way winner-take-most platform, but the nearer-term trade is really about addressable market breadth versus technical purity. IONQ’s higher fidelity matters less as a commercialization milestone than as a fundraising and multiple-support event: it improves the probability of continued capital access, but not necessarily the probability of near-term revenue inflection. QBTS, by contrast, may be less “sexy” technically, yet its narrower use cases could convert into earlier customer proof points because optimization buyers can justify pilots on incremental ROI rather than scientific breakthrough.

The second-order issue is that both names are still in the phase where equity performance is driven more by narrative elasticity than operating leverage. That makes them highly sensitive to any change in the cost of capital: a risk-off tape or a failed enterprise pilot can compress multiples quickly because neither business has enough recurring revenue to absorb sentiment shocks. The current rebound also invites supply overhang from earlier retail holders and any opportunistic financing, which can cap upside even if the secular story stays intact.

Contrarian read: the better short-term setup may be to fade the more crowded winner, not the structurally weaker company. IONQ likely deserves the premium, but that premium is now doing most of the work; if execution slips even modestly, the stock has more to lose because expectations are higher and the shareholder base is more momentum-sensitive. QBTS may actually offer a cleaner asymmetric trade if one believes in a multi-year pilot cycle, because lower expectations and smaller capitalization can translate into sharper upside on a single credible commercial announcement.

Key Decisions for Investors

• Long IONQ / short QBTS as a 3-6 month relative-value trade: own the platform with broader TAM and better fundraising optionality, but hedge quantum sector beta; target 15-20% spread capture if IONQ continues to outperform on technical validation.
• If chasing momentum, buy IONQ only on pullbacks rather than strength: use 4-8 week entry windows after >10% retraces to avoid paying peak narrative premium; stop if enterprise commentary fails to convert into backlog signals.
• For higher-risk upside exposure, consider small QBTS call spreads 6-12 months out: cheaper convexity than stock, with payoff tied to a single commercialization catalyst; size modestly because downside is dominated by dilution risk.
• Avoid unhedged long-only exposure to either name into any market-wide risk-off move: both are duration-sensitive, and a 5-10% rise in real rates can compress speculative software/compute multiples even if company-specific news remains constructive.
• Use any post-rally financing announcement as a tactical short signal in both names: these stocks are vulnerable to dilution-driven 10-15% drawdowns within days when capital raises validate the cash burn narrative.